1. Home
  2. NTLA vs FUN Comparison

NTLA vs FUN Comparison

Compare NTLA & FUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$17.38

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

HOLD

Current Price

$21.02

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTLA
FUN
Founded
2014
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
NTLA
FUN
Price
$17.38
$21.02
Analyst Decision
Buy
Buy
Analyst Count
23
12
Target Price
$20.02
$23.75
AVG Volume (30 Days)
6.7M
2.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.43
N/A
EPS
N/A
N/A
Revenue
$67,671,000.00
$3,100,289,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
$62.75
$3.74
P/E Ratio
N/A
N/A
Revenue Growth
16.92
14.45
52 Week Low
$7.95
$12.51
52 Week High
$28.24
$33.50

Technical Indicators

Market Signals
Indicator
NTLA
FUN
Relative Strength Index (RSI) 69.19 46.39
Support Level $11.73 $20.26
Resistance Level $27.61 $21.22
Average True Range (ATR) 1.21 1.46
MACD 0.28 -0.44
Stochastic Oscillator 84.38 18.56

Price Performance

Historical Comparison
NTLA
FUN

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

Share on Social Networks: